Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive, according to a “game-changer” study. Patients with advanced (muscle ...

Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patients - Experts said Durvalumab ...